1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Previous fractures
Cortoss (n = 162) PMMA (n = 94) Total (n = 256) No. of patients with any previous fracturesa 56 (34.6%) 31 (33.0%) 87 (34.0%) Total no. of levels with previous fracturesb 106 60 166 No. of patients with any previous fractures (treated)c 20 (12.3%) 13 (13.8%) 33 (12.9%) Total no. of levels with previous fractures (treated) 33 25 58 No. of patients with any previous fractures (untreated)d 39 (24.1%) 21 (22.3%) 60 (23.4%) Total no. of levels with previous fractures (untreated)e 73 35 108
↵a Excludes pre-existing untreated fractures that were treated along with the acute fracture in the current study. Includes treated and untreated fractures other than the index treated levels.
↵b Includes all levels with previously treated fractures and all levels with previous untreated fractures, excluding those levels treated in the current study.
↵c No. and percentage of patients with any previous fractures treated with vertebral augmentation.
↵d Excludes untreated levels treated in the current study.
↵e Excludes levels treated in the current study.